Table 1.

Clinical Characteristics of (NSCLC, Adenocarcinoma) Patients and HD Enrolled in This Study

Patient No.	Gender	Age (Y)	Smoking history (Y)	Tumor grade	Clinical stage	Gene status (Tissue)b	Copy numbers ofT790M mutation/ROSl rearrangement in EVsa
R01	Female	62	None	3	IIIB	CD74-ROS1	18
R02	Male	41	None	2	hib	CD74-ROS1	27
R03	Male	61	35	2	IV	CD74-ROS1	54
R04	Male	34	None	3	TV	CD74-ROS1	54
R05	Male	61	35	2	IV	CD74-ROS1	99
R06	Male	34	None	3	IV	CD74-ROS1	396
R07-1	Male	32	None	3	IV	CD74-ROS1	324
R07-2	Male	32	None	3	IV	N/A	0
R07-3	Male	32	None	3	IV	N/A	468
E01	Female	55	None	3	IV	T790M	36
E02	Female	62	None	3	TV	T790M	36
E03	Male	66	None	3	IV	T790M	90
E04-1	Male	53	None	3	IV	N/A	0
E04-2	Male	53	None	3	IV	T790M	225
E04-3	Male	53	None	3	IV	N/A	9
E05	Male	62	None	2	IV	T790M	72
E06	Male	61	None	2	IV	T790M	81
HD01	Male	30	None	N/A	N/A	N/A	0
HD02	Male	26	None	N/A	N/A	N/A	0
HD03	Male	29	None	N/A	N/A	N/A	0
HD04	Male	46	None	N/A	N/A	N/A	0
HD05	Female	36	None	N/A	N/A	N/A	0
HD06	Male	32	None	N/A	N/A	N/A	0
HD07	Male	56	None	N/A	N/A	N/A	0
HD08	Female	58	None	N/A	N/A	N/A	0
HD09	Male	60	None	N/A	N/A	N/A	0

^aPer 0.2 mL plasma.

^bN/A: not available.